Monthly information on share capital and company voting rights

Rhea-AI Summary

Cellectis (CLLS) has released its monthly share capital and voting rights report as of August 31, 2025. The company reported a total of 100,325,229 shares in its capital structure and 89,428,230 voting rights. This disclosure is made in accordance with Article 223-16 of the General Regulation of the French financial markets authority for companies listed on Euronext Growth.

PARIS, Sept. 03, 2025 (GLOBE NEWSWIRE) --

(Article 223-16 of General Regulation of the French financial markets authority)

Listing market: Euronext Growth

ISIN code: FR0010425595

Date	Total number of shares in the capital	Total number of voting rights
08/31/2025	100,325,229	89,428,230

 

For further information on Cellectis, please contact: 
Media contacts:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93

Investor Relations contact:
Arthur Stril, Chief Financial Officer & Chief Business Officer, investors@cellectis.com 

Attachment

• Voting_Rights_PR_August_2025_EN

FAQ

What is the current total number of shares outstanding for Cellectis (CLLS)?

As of August 31, 2025, Cellectis has 100,325,229 total shares outstanding in its capital structure.

How many voting rights does Cellectis (CLLS) have as of August 2025?

Cellectis reported 89,428,230 total voting rights as of August 31, 2025.

Why is there a difference between Cellectis (CLLS) total shares and voting rights?

The difference may be due to factors such as treasury shares or certain share classes with different voting rights under French corporate law.

How often does Cellectis (CLLS) report its share capital and voting rights information?

Cellectis reports its share capital and voting rights information monthly, in accordance with Article 223-16 of the French financial markets authority regulations.